Association between pharmacologic treatment and hospital utilization at birth among neonatal opioid withdrawal syndrome mother-infant dyads

Bateman BT, Hernandez-Diaz S, Rathmell JP, Seeger JD, Doherty M, Fischer MA, et al. Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology. 2014;120:1216–24.

Google Scholar 

Brown JD, Doshi PA, Pauly NJ, Talbert JC. Rates of neonatal abstinence syndrome amid efforts to combat the opioid abuse epidemic. JAMA Pediatr. 2016;170:1110–2.

Google Scholar 

Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35:650–5.

CAS 

Google Scholar 

Pryor JR, Maalouf FI, Krans EE, Schumacher RE, Cooper WO, Patrick SW. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care. Arch Dis Child Fetal Neonatal Ed. 2017;102:F183–F7.

Google Scholar 

Villapiano NL, Winkelman TN, Kozhimannil KB, Davis MM, Patrick SW. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pediatr. 2017;171:194–6.

Google Scholar 

Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, et al. Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. J Perinatol. 2018;38:1114–22.

Google Scholar 

Patrick SW, Kaplan HC, Passarella M, Davis MM, Lorch SA. Variation in treatment of neonatal abstinence syndrome in US children’s hospitals, 2004-2011. J Perinatol. 2014;34:867–72.

CAS 

Google Scholar 

Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician. 2007;53:1723–30.

Google Scholar 

Holmes AV, Atwood EC, Whalen B, Beliveau J, Jarvis JD, Matulis JC, et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics. 2016;137:e20152929.

Grossman MR, Berkwitt AK, Osborn RR, Xu Y, Esserman DA, Shapiro ED, et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics. 2017;139:e20163360.

Grossman MR, Osborn RR, Berkwitt AK. Neonatal abstinence syndrome: time for a reappraisal. Hosp Pediatr. 2017;7:115–6.

Google Scholar 

MacMillan KDL. Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes. Clin Perinatol. 2019;46:817–32.

Google Scholar 

Singh R, Houghton M, Melvin P, Wachman EM, Diop H, Iverson R, Jr., et al. Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database. J Perinatol. 2021;41:1381–8.

Patrick SW, Barfield WD, Poindexter BB, Committee On Fetus and Newborn, Committee on Substance Use and Prevention. Neonatal opioid withdrawal syndrome. Pediatrics. 2020;146:e2020029074.

Howard MB, Schiff DM, Penwill N, Si W, Rai A, Wolfgang T, et al. Impact of parental presence at infants’ bedside on neonatal abstinence syndrome. Hosp Pediatr. 2017;7:63–9.

Google Scholar 

Wachman EM, Houghton M, Melvin P, Isley BC, Murzycki J, Singh R, et al. A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts’ PNQIN collaborative. J Perinatol. 2020;40:1560–9.

CAS 

Google Scholar 

Grisham LM, Stephen MM, Coykendall MR, Kane MF, Maurer JA, Bader MY. Eat, sleep, console approach: a family-centered model for the treatment of neonatal abstinence syndrome. Adv Neonatal Care. 2019;19:138–44.

Google Scholar 

Blount T, Painter A, Freeman E, Grossman M, Sutton AG. Reduction in length of stay and morphine use for NAS With the “Eat, Sleep, Console” Method. Hosp Pediatr. 2019;9:615–23.

Google Scholar 

Milliren CE, Gupta M, Graham DA, Melvin P, Jorina M, Ozonoff A. Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016. Hosp Pediatr. 2018;8:15–20.

Google Scholar 

Bogen DL, Whalen BL, Kair LR, Vining M, King BA. Wide variation found in care of opioid-exposed newborns. Acad Pediatr. 2017;17:374–80.

Google Scholar 

Oesterle TS, Thusius NJ, Rummans TA, Gold MS. Medication-assisted treatment for opioid-use disorder. Mayo Clin Proc. 2019;94:2072–86.

Google Scholar 

Jones HE, Chisolm MS, Jansson LM, Terplan M. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction. 2013;108:233–47.

Google Scholar 

American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130:e81–94.

Google Scholar 

Substance Abuse and Mental Health Services Administration. Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants. Rockville, MD; 2018. Contract No.: HHS Publication No. (SMA) 18-5054.

Wiegand SL, Stringer EM, Stuebe AM, Jones H, Seashore C, Thorp J. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstet Gynecol. 2015;125:363–8.

CAS 

Google Scholar 

Towers CV, Hyatt BW, Visconti KC, Chernicky L, Chattin K, Fortner KB. Neonatal head circumference in newborns with neonatal abstinence syndrome. Pediatrics. 2019;143:e20180541.

Coulson CC, Lorencz E, Rittenhouse K, Ramage M, Lorenz K, Galvin SL. Association of maternal buprenorphine or methadone dose with fetal growth indices and neonatal abstinence syndrome. Am J Perinatol. 2021;38:28–36.

Google Scholar 

Ramage M, Ostrach B, Fagan B, Coulson CC. Stabilizing the mother-infant dyad for better outcomes from OB to FM: Caring for patients with perinatal opioid use disorder through the 4th trimester. North Carol Med J. 2018;79:164–5.

Google Scholar 

Stover MW, Davis JM. Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol. 2015;39:561–5.

Google Scholar 

Scott LF, Guilfoy V, Duwve JM, Rawl SM, Cleveland L. Factors associated with the need for pharmacological management of neonatal opioid withdrawal syndrome. Adv Neonatal Care. 2020;20:364–73.

Google Scholar 

Honein MA, Boyle C, Redfield RR. Public health surveillance of prenatal opioid exposure in mothers and infants. Pediatrics. 2019;143:e20183801.

Hahn PD, Melvin P, Graham DA, Milliren CE. A methodology to create mother-baby dyads using data from the Pediatric Health Information System. Hosp Pediatr. 2022;12:884–92.

Milliren CE, Melvin P, Ozonoff A. Pediatric hospital readmissions for infants with neonatal opioid withdrawal syndrome, 2016–2019. Hosp Pediatr. 2021;11:979–87.

Google Scholar 

Keren R, Luan X, Localio R, Hall M, McLeod L, Dai D, et al. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166:1155–64.

Google Scholar 

Jonas JA, Shah SS, Zaniletti I, Hall M, Colvin JD, Gottlieb LM, et al. Regional variation in standardized costs of care at children’s hospitals. J Hosp Med. 2017;12:818–25.

Google Scholar 

Congressional Budget Office. The Distribution of Household Income, 2016. 2019. https://www.cbo.gov/publication/55413.

Ton TG, Bennett MV, Incerti D, Peneva D, Druzin M, Stevens W, et al. Maternal and infant adverse outcomes associated with mild and severe preeclampsia during the first year after delivery in the United States. Am J Perinatol. 2020;37:398–408.

Google Scholar 

Blake HA, Sharples LD, Harron K, van der Meulen JH, Walker K. Probabilistic linkage without personal information successfully linked national clinical datasets. J Clin Epidemiol. 2021;136:136–45.

Google Scholar 

Johnson KE, Beaton SJ, Andrade SE, Cheetham TC, Scott PE, Hammad TA, et al. Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf. 2013;22:776–82.

Google Scholar 

Vigod SN, Gomes T, Wilton AS, Taylor VH, Ray JG. Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study. BMJ. 2015;350:h2298.

Clark RRS, French R, Lorch S, O’Rourke K, Rosenbaum KEF, Lake ET. Within-hospital concordance of opioid exposure diagnosis coding in mothers and newborns. Hosp Pediatr. 2021;11:825–33.

Google Scholar 

Goyal S, Saunders KC, Moore CS, Fillo KT, Ko JY, Manning SE, et al. Identification of substance-exposed newborns and neonatal abstinence syndrome using ICD-10-CM—15 hospitals, Massachusetts, 2017. Morb Mortal Wkly Rep. 2020;69:951.

CAS 

Google Scholar 

Maalouf FI, Cooper WO, Stratton SM, Dudley JA, Ko J, Banerji A, et al. Positive predictive value of administrative data for neonatal abstinence syndrome. Pediatrics. 2019;143: e20174183.

Peeler M, Gupta M, Melvin P, Bryant AS, Diop H, Iverson R, et al. Racial and ethnic disparities in maternal and infant outcomes among opioid-exposed mother-infant dyads in Massachusetts (2017–2019). Am J Public Health. 2020;110:1828–36.

Google Scholar 

Schiff DM, Nielsen T, Hoeppner BB, Terplan M, Hansen H, Bernson D, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Netw Open. 2020;3:e205734.

Google Scholar 

Guerrero EG, Marsh JC, Duan L, Oh C, Perron B, Lee B. Disparities in completion of substance abuse treatment between and within racial and ethnic groups. Health Serv Res. 2013;48:1450–67.

Google Scholar 

Cook BL, Alegria M. Racial-ethnic disparities in substance abuse treatment: the role of criminal history and socioeconomic status. Psychiatr Serv. 2011;62:1273–81.

Google Scholar 

Pinedo M. A current re-examination of racial/ethnic disparities in the use of substance abuse treatment: Do disparities persist? Drug Alcohol Depend. 2019;202:162–7.

Google Scholar 

Elmore AL, Tanner JP, Lowry J, Lake-Burger H, Kirby RS, Hudak ML, et al. Diagnosis codes and case definitions for neonatal abstinence syndrome. Pediatrics. 2020;146:e20200567.

Wen T, Batista N, Wright JD, D’Alton ME, Attenello FJ, Mack WJ, et al. Postpartum readmissions among women with opioid use disorder. Am J Obstet Gynecol MFM. 2019;1:89–98.

Google Scholar 

Patrick SW, Burke JF, Biel TJ, Auger KA, Goyal NK, Cooper WO. Risk of hospital readmission among infants with neonatal abstinence syndrome. Hosp Pediatr. 2015;5:513–9.

Google Scholar 

Shrestha S, Roberts MH, Maxwell JR, Leeman LM, Bakhireva LN. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome. Neurotoxicol Teratol. 2021;86:106975.

CAS 

Google Scholar 

Hwang SS, Liu CL, Yu Q, Cui X, Diop H. Risk factors for emergency room use and rehospitalization among opioid-exposed newborns in Massachusetts. Birth. 2021;48:26–35.

Google Scholar 

Lappen JR, Stark S, Bailit JL, Gibson KS. Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome. Am J Obstet Gynecol MFM. 2020;2:100075.

Google Scholar